Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Dermatology

What Are Early Bullous Pemphigoid Relapse Symptoms?

At a Glance

An early bullous pemphigoid relapse may cause severe itching or persistent hive-like or eczema-like patches before firm blisters appear. New symptoms should be assessed by a dermatologist, while eye, airway, or severe infection symptoms need urgent care.

If you have been in remission (a period where your disease is quiet and controlled) from bullous pemphigoid, it is natural to wonder how a relapse (a return of disease activity) might look. While some relapses start directly with new blisters, many people first notice intense, unexplained itching (pruritus) or a hive-like rash before any blisters form [1][2]. Recognizing these possible early signs can help you seek medical assessment sooner, which may allow your care team to adjust your treatment before a full flare-up occurs [3].

The Early (Prodromal) Phase

In the weeks or months before blisters appear, your skin may show other changes [1]. This non-blistering stage is known as the prodromal phase. Common early signs can include:

  • Intense Itching (Pruritus): A return of severe, persistent itching is often the earliest clue [4].
  • Urticarial Plaques: These are raised, red, hive-like patches. While typical allergic hives usually fade within 24 hours in a single spot, these plaques persist and do not go away quickly [5].
  • Eczema-like Rashes: You may develop dry, red, or scaly patches that resemble eczema [6].

Because these symptoms can also be caused by dry skin, new medications, or common allergies, an itch or rash does not automatically mean your bullous pemphigoid has returned. However, it does warrant a check-in with your doctor.

Progression to Blistering

If early signs are part of a relapse, they may eventually progress to a full blistering flare-up, though this is not inevitable for everyone:

  • Tense Blisters: The classic symptom of bullous pemphigoid is the appearance of firm, fluid-filled blisters (bullae). These often form on top of the red, hive-like patches or on normal-appearing skin [7][8].
  • Common Locations: Blisters most frequently appear on the arms, legs, and trunk [9].
  • Erosions: As blisters break, they leave behind raw, painful sores called erosions [7], which can be vulnerable to infection.

How common is a relapse? Relapse estimates vary widely—from roughly 28% to 74%—depending on the specific clinical study, the treatments used, and how long patients were followed [10][11]. Research suggests that many relapses occur within the first six months after reaching remission, but they can still happen later on [10].

Mucous Membrane Symptoms and Urgent Care

In a minority of cases, bullous pemphigoid can affect the mucous membranes—the moist linings of your mouth, throat, eyes, and genitals [12]. While mucosal involvement does not automatically mean your overall disease is more severe, it requires prompt medical attention [13].

Seek urgent or emergency medical care if you experience:

  • Vision changes or eye pain: Severe redness, pain, light sensitivity, or a gritty feeling in your eyes require urgent ophthalmic assessment, as scarring can threaten your vision [14].
  • Throat or airway issues: Difficulty breathing, throat swelling, hoarseness, or an inability to swallow liquids warrant immediate emergency care [15][16].
  • Signs of severe infection: Rapidly spreading blisters, fever, extreme dehydration, or increased warmth, swelling, and pus around open erosions require prompt escalation.

What to Do if You Suspect a Relapse

If you notice new or worsening symptoms compared to your baseline, contact your dermatologist promptly.

  • Do not change your medications: Never restart, stop, or adjust your prescribed steroids or immunosuppressive drugs without your doctor’s supervision.
  • Be cautious with over-the-counter (OTC) treatments: If you need interim itch relief, ask your pharmacist or doctor before taking OTC antihistamines. Because many patients with bullous pemphigoid are older adults, sedating antihistamines (like diphenhydramine) can increase the risk of falls, confusion, and urinary issues.
  • Prepare for your appointment: Take dated photographs of new rashes or blisters in good light, and bring a current list of all your medications.

How your doctor will check for a relapse:
A skin examination is the first step. Your doctor may run blood tests (such as the BP180 and BP230 antibody tests) as supportive tools; however, these blood tests cannot definitively prove or rule out a relapse on their own, as antibodies can remain detectable even when the disease is quiet [17][18]. Ultimately, diagnosis depends on your clinical symptoms, and your doctor will decide if a repeat skin biopsy (taking small samples of affected and unaffected skin for specialized testing) is needed [17].

Common questions in this guide

What are the first signs of a bullous pemphigoid relapse?
Severe, persistent itching is often the earliest clue. Some people also develop persistent hive-like raised patches or dry, red, scaly areas before firm blisters appear, although itching or a rash can have other causes.
Can bullous pemphigoid return without blisters?
Yes. A relapse may begin in a non-blistering stage with itching, hive-like plaques, or an eczema-like rash, and it does not always progress to blisters. New or worsening symptoms should be assessed by a clinician.
How is a bullous pemphigoid relapse confirmed?
A clinician starts with a skin examination. BP180 and BP230 blood tests can support the assessment but cannot confirm or rule out relapse on their own, because antibodies may remain detectable when the disease is quiet. A repeat skin biopsy may be needed.
When should I seek urgent care for a bullous pemphigoid flare?
Get urgent help for eye pain, severe redness, light sensitivity, or vision changes, because scarring can threaten sight. Go to emergency care for throat swelling, trouble breathing, hoarseness, or inability to swallow liquids, and promptly seek care for rapidly spreading blisters, fever, dehydration, or signs of infection.
Should I restart my bullous pemphigoid medicine if symptoms return?
No. Do not restart, stop, or change steroids or immunosuppressive medicines without the prescribing clinician's guidance. Ask a clinician or pharmacist before using an over-the-counter antihistamine; sedating products can increase falls, confusion, and urinary problems, especially in older adults.
How soon can bullous pemphigoid relapse after remission?
Relapse estimates vary from about 28% to 74% across studies because researchers used different treatments and follow-up periods. Many relapses occur within six months after remission, but a relapse can happen later.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How quickly should I contact your office if I experience intense itching or persistent red patches without blisters?
  2. 2.If I suspect a relapse, do you recommend any safe over-the-counter anti-itch treatments I can use while waiting for my appointment?
  3. 3.Will we need to do another skin biopsy to confirm a relapse, or will a clinical exam and blood tests be sufficient?
  4. 4.If a relapse is confirmed, how will we adjust my treatment plan, and will we restart my previous medication?
  5. 5.Which specific symptoms (such as mouth sores or eye irritation) should prompt me to go to urgent care instead of waiting for a regular appointment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Bullous Pemphigoid: A Multifactorial Review of a Dermatologic Mystery.

    Martinez N, Gadler T, Benson A, et al.

    Advanced emergency nursing journal 2021; (43(4)):272-278 doi:10.1097/TME.0000000000000372.

    PMID: 34699416
  2. 2

    Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.

    Bernard P, Antonicelli F

    American journal of clinical dermatology 2017; (18(4)):513-528 doi:10.1007/s40257-017-0264-2.

    PMID: 28247089
  3. 3

    Bullous pemphigoid: Three main clusters defining 3 outcome profiles.

    Guerrois F, Hassan E, Bettuzzi T, et al.

    Journal of the American Academy of Dermatology 2022; (87(2)):359-365 doi:10.1016/j.jaad.2022.04.029.

    PMID: 35483492
  4. 4

    Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).

    Borradori L, Van Beek N, Feliciani C, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(10)):1689-1704 doi:10.1111/jdv.18220.

    PMID: 35766904
  5. 5

    A Systematic Review of Drug-Induced Pemphigoid.

    Verheyden MJ, Bilgic A, Murrell DF

    Acta dermato-venereologica 2020; (100(15)):adv00224 doi:10.2340/00015555-3457.

    PMID: 32176310
  6. 6

    Advances in understanding and managing bullous pemphigoid.

    Zhao CY, Murrell DF

    F1000Research 2015; (4()).

    PMID: 26918143
  7. 7

    Annular bullous pemphigoid: A case report and review of literature.

    Arès S, Lim D, Jung S, et al.

    SAGE open medical case reports 2022; (10()):2050313X221093128 doi:10.1177/2050313X221093128.

    PMID: 35495292
  8. 8

    Bullous pemphigoid.

    Akbarialiabad H, Schmidt E, Patsatsi A, et al.

    Nature reviews. Disease primers 2025; (11(1)):12 doi:10.1038/s41572-025-00595-5.

    PMID: 39979318
  9. 9

    Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen Expression.

    Rastegar Lari T, Macias L, Robrahn L, et al.

    Life (Basel, Switzerland) 2025; (15(2)) doi:10.3390/life15020218.

    PMID: 40003627
  10. 10

    Relapse of bullous pemphigoid: an update on this stubborn clinical problem.

    Wang Y, Mao X, Wang Y, et al.

    Annals of medicine 2018; (50(3)):234-239 doi:10.1080/07853890.2018.1443346.

    PMID: 29457514
  11. 11

    Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China.

    Cao S, Li W, Wang Z, et al.

    American journal of clinical dermatology 2025; (26(3)):457-470 doi:10.1007/s40257-025-00925-z.

    PMID: 40059256
  12. 12

    Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid.

    Kridin K, Bergman R

    JAMA dermatology 2019; (155(2)):166-171 doi:10.1001/jamadermatol.2018.5049.

    PMID: 30624571
  13. 13

    Mucosal Involvement in Bullous Pemphigoid: Severity Indicator and Associated Clinical Features from a Retrospective Cohort Study.

    Cui S, Zhang B, Chen F, et al.

    Journal of inflammation research 2026; (19()):608150 doi:10.2147/JIR.S608150.

    PMID: 42339303
  14. 14

    A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes.

    Kate A, Shanbhag S, Donthineni PR, Basu S

    F1000Research 2021; (10()):1201 doi:10.12688/f1000research.75120.2.

    PMID: 35136583
  15. 15

    Laryngeal Bullous Pemphigoid: A challenging presentation of a rare disease.

    Smaily H, Crouslé M, Hanna E

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025; (282(10)):5397-5403 doi:10.1007/s00405-025-09506-6.

    PMID: 40533610
  16. 16

    Esophageal involvement in Bullous pemphigoid: Case report.

    Zahraoui S, Benjelloun N, Salihoun M, et al.

    SAGE open medical case reports 2024; (12()):2050313X241279726 doi:10.1177/2050313X241279726.

    PMID: 39314220
  17. 17

    Nonbullous pemphigoid: A systematic review.

    Lamberts A, Meijer JM, Jonkman MF

    Journal of the American Academy of Dermatology 2018; (78(5)):989-995.e2 doi:10.1016/j.jaad.2017.10.035.

    PMID: 29102490
  18. 18

    Bullous pemphigoid.

    Miyamoto D, Santi CG, Aoki V, Maruta CW

    Anais brasileiros de dermatologia 2019; (94(2)):133-146 doi:10.1590/abd1806-4841.20199007.

    PMID: 31090818

This page is for informational purposes only and does not constitute medical advice. It explains possible bullous pemphigoid relapse symptoms; contact your dermatologist promptly and seek emergency care for breathing, swallowing, or vision problems.

Get notified when new evidence is published on Bullous pemphigoid.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.